| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Delirium | 38 | 2024 | 1667 | 3.310 |
Why?
|
| Magnetic Resonance Imaging, Cine | 12 | 2024 | 1048 | 1.040 |
Why?
|
| Chronic Periodontitis | 3 | 2014 | 101 | 0.850 |
Why?
|
| Postoperative Complications | 25 | 2024 | 15609 | 0.740 |
Why?
|
| Blood Proteins | 4 | 2024 | 1172 | 0.730 |
Why?
|
| Thiamine | 5 | 2024 | 160 | 0.710 |
Why?
|
| Magnetic Resonance Imaging | 40 | 2024 | 36401 | 0.690 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 7 | 2015 | 133 | 0.690 |
Why?
|
| Mass Screening | 4 | 2021 | 5425 | 0.680 |
Why?
|
| Defibrillators, Implantable | 4 | 2024 | 1483 | 0.680 |
Why?
|
| Cardiomyopathies | 5 | 2024 | 1948 | 0.640 |
Why?
|
| Aged | 143 | 2024 | 169092 | 0.620 |
Why?
|
| Myocardium | 15 | 2024 | 4725 | 0.610 |
Why?
|
| Shock, Septic | 7 | 2023 | 769 | 0.610 |
Why?
|
| Multiple Sclerosis | 3 | 2023 | 3222 | 0.610 |
Why?
|
| Authorship | 4 | 2018 | 284 | 0.590 |
Why?
|
| Primary Prevention | 2 | 2024 | 1185 | 0.590 |
Why?
|
| Reminder Systems | 2 | 2018 | 386 | 0.570 |
Why?
|
| Female | 203 | 2024 | 392203 | 0.560 |
Why?
|
| Gadolinium | 7 | 2024 | 959 | 0.540 |
Why?
|
| Breast Neoplasms | 13 | 2024 | 20988 | 0.530 |
Why?
|
| Aged, 80 and over | 73 | 2024 | 58919 | 0.530 |
Why?
|
| Gingival Crevicular Fluid | 2 | 2014 | 94 | 0.530 |
Why?
|
| Humans | 278 | 2024 | 760740 | 0.520 |
Why?
|
| Image Interpretation, Computer-Assisted | 12 | 2022 | 3356 | 0.520 |
Why?
|
| Subthalamic Nucleus | 1 | 2018 | 195 | 0.510 |
Why?
|
| Male | 186 | 2024 | 360402 | 0.510 |
Why?
|
| Proteomics | 11 | 2024 | 3836 | 0.500 |
Why?
|
| JC Virus | 6 | 2015 | 87 | 0.490 |
Why?
|
| Furcation Defects | 1 | 2014 | 37 | 0.480 |
Why?
|
| Middle Aged | 126 | 2024 | 220603 | 0.480 |
Why?
|
| Contrast Media | 15 | 2024 | 5305 | 0.470 |
Why?
|
| Cardiomyopathy, Dilated | 4 | 2024 | 831 | 0.470 |
Why?
|
| Patient Care Planning | 2 | 2017 | 905 | 0.470 |
Why?
|
| Periodontal Pocket | 1 | 2014 | 171 | 0.470 |
Why?
|
| Thiamine Deficiency | 2 | 2016 | 48 | 0.470 |
Why?
|
| Hospitalization | 13 | 2022 | 10708 | 0.460 |
Why?
|
| Molar | 1 | 2014 | 156 | 0.460 |
Why?
|
| Tooth Root | 1 | 2014 | 162 | 0.460 |
Why?
|
| Electronic Health Records | 8 | 2024 | 4810 | 0.450 |
Why?
|
| Predictive Value of Tests | 32 | 2024 | 15250 | 0.450 |
Why?
|
| Insulin | 4 | 2023 | 6593 | 0.440 |
Why?
|
| Arrhythmias, Cardiac | 7 | 2024 | 2234 | 0.440 |
Why?
|
| Prospective Studies | 55 | 2024 | 54364 | 0.430 |
Why?
|
| Patient Discharge | 7 | 2024 | 3442 | 0.420 |
Why?
|
| Organometallic Compounds | 4 | 2019 | 646 | 0.410 |
Why?
|
| Periodontal Attachment Loss | 1 | 2012 | 147 | 0.410 |
Why?
|
| Patient Participation | 4 | 2024 | 1443 | 0.400 |
Why?
|
| Intracranial Thrombosis | 2 | 2023 | 108 | 0.400 |
Why?
|
| Image Enhancement | 13 | 2019 | 2881 | 0.390 |
Why?
|
| Adult | 113 | 2024 | 220995 | 0.390 |
Why?
|
| Sepsis | 10 | 2011 | 2585 | 0.380 |
Why?
|
| Maxilla | 1 | 2014 | 494 | 0.380 |
Why?
|
| Models, Statistical | 7 | 2016 | 5074 | 0.380 |
Why?
|
| Publishing | 4 | 2018 | 832 | 0.380 |
Why?
|
| Heart | 10 | 2022 | 4403 | 0.380 |
Why?
|
| Geriatric Assessment | 6 | 2023 | 1411 | 0.370 |
Why?
|
| Orthopedic Procedures | 5 | 2023 | 1265 | 0.370 |
Why?
|
| Endometriosis | 3 | 2024 | 857 | 0.370 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 506 | 0.360 |
Why?
|
| C-Reactive Protein | 6 | 2021 | 3820 | 0.350 |
Why?
|
| Multiple Organ Failure | 4 | 2020 | 387 | 0.350 |
Why?
|
| Learning Curve | 1 | 2012 | 230 | 0.340 |
Why?
|
| Deep Brain Stimulation | 1 | 2018 | 831 | 0.340 |
Why?
|
| Vocabulary, Controlled | 3 | 2007 | 167 | 0.340 |
Why?
|
| Confusion | 4 | 2023 | 278 | 0.340 |
Why?
|
| Physicians | 4 | 2024 | 4583 | 0.330 |
Why?
|
| Women's Health | 5 | 2024 | 2066 | 0.330 |
Why?
|
| Magnetic Resonance Angiography | 6 | 2011 | 1431 | 0.330 |
Why?
|
| Risk Factors | 44 | 2024 | 74128 | 0.320 |
Why?
|
| Risk Assessment | 21 | 2024 | 23974 | 0.320 |
Why?
|
| Acidosis, Lactic | 1 | 2010 | 146 | 0.310 |
Why?
|
| Mammography | 6 | 2024 | 2430 | 0.310 |
Why?
|
| Sample Size | 1 | 2012 | 838 | 0.310 |
Why?
|
| General Practice | 3 | 2020 | 97 | 0.310 |
Why?
|
| Cardiomyopathy, Hypertrophic | 3 | 2023 | 1310 | 0.310 |
Why?
|
| Problem-Based Learning | 1 | 2012 | 356 | 0.310 |
Why?
|
| Analgesics, Opioid | 5 | 2024 | 3805 | 0.300 |
Why?
|
| Cytokines | 3 | 2019 | 7373 | 0.300 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2023 | 12143 | 0.300 |
Why?
|
| Hospitalists | 2 | 2022 | 294 | 0.290 |
Why?
|
| Case-Control Studies | 19 | 2024 | 22153 | 0.290 |
Why?
|
| Ventricular Function, Left | 10 | 2024 | 3873 | 0.290 |
Why?
|
| Occupational Therapy | 1 | 2009 | 139 | 0.290 |
Why?
|
| Postmenopause | 1 | 2016 | 2511 | 0.290 |
Why?
|
| Medicare | 15 | 2024 | 6774 | 0.290 |
Why?
|
| Insurance, Life | 1 | 2007 | 14 | 0.280 |
Why?
|
| Reproducibility of Results | 26 | 2023 | 20077 | 0.280 |
Why?
|
| Radiology | 4 | 2018 | 2113 | 0.280 |
Why?
|
| Biomedical Research | 5 | 2018 | 3426 | 0.280 |
Why?
|
| Insurance, Disability | 1 | 2007 | 26 | 0.280 |
Why?
|
| Primary Health Care | 3 | 2019 | 4677 | 0.280 |
Why?
|
| Patients | 3 | 2023 | 906 | 0.270 |
Why?
|
| Periodicals as Topic | 3 | 2013 | 1463 | 0.270 |
Why?
|
| Decision Making | 4 | 2024 | 3919 | 0.270 |
Why?
|
| Venous Thrombosis | 3 | 2023 | 1303 | 0.260 |
Why?
|
| Logistic Models | 17 | 2024 | 13248 | 0.260 |
Why?
|
| Administration, Intranasal | 3 | 2022 | 476 | 0.260 |
Why?
|
| Health Education | 3 | 2007 | 1049 | 0.250 |
Why?
|
| Meglumine | 2 | 2019 | 143 | 0.250 |
Why?
|
| Patient Access to Records | 4 | 2016 | 119 | 0.240 |
Why?
|
| Activities of Daily Living | 5 | 2020 | 2419 | 0.240 |
Why?
|
| Doxorubicin | 2 | 2024 | 2224 | 0.240 |
Why?
|
| Disabled Persons | 6 | 2013 | 1226 | 0.240 |
Why?
|
| Severity of Illness Index | 13 | 2023 | 15829 | 0.240 |
Why?
|
| Pelvic Pain | 2 | 2024 | 292 | 0.240 |
Why?
|
| Cicatrix | 4 | 2023 | 785 | 0.240 |
Why?
|
| Parkinson Disease | 1 | 2018 | 2878 | 0.230 |
Why?
|
| Neuropsychological Tests | 7 | 2020 | 7050 | 0.230 |
Why?
|
| Imaging, Three-Dimensional | 9 | 2018 | 4058 | 0.230 |
Why?
|
| Early Detection of Cancer | 2 | 2015 | 3196 | 0.230 |
Why?
|
| Retrospective Studies | 40 | 2024 | 80583 | 0.230 |
Why?
|
| Alzheimer Disease | 4 | 2024 | 8603 | 0.230 |
Why?
|
| Health Personnel | 2 | 2017 | 3333 | 0.230 |
Why?
|
| Ozone | 7 | 2005 | 483 | 0.230 |
Why?
|
| Dementia | 4 | 2023 | 2686 | 0.220 |
Why?
|
| Patient Preference | 2 | 2024 | 925 | 0.220 |
Why?
|
| Cardiovascular Diseases | 5 | 2024 | 15498 | 0.220 |
Why?
|
| Sensitivity and Specificity | 21 | 2023 | 14649 | 0.220 |
Why?
|
| Algorithms | 15 | 2016 | 14024 | 0.220 |
Why?
|
| Cause of Death | 7 | 2016 | 3683 | 0.210 |
Why?
|
| Respiratory-Gated Imaging Techniques | 3 | 2012 | 75 | 0.210 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 2 | 2013 | 61 | 0.210 |
Why?
|
| Coronary Vessels | 5 | 2012 | 3095 | 0.210 |
Why?
|
| Nursing Assessment | 2 | 2021 | 106 | 0.200 |
Why?
|
| Physicians, Primary Care | 3 | 2015 | 618 | 0.200 |
Why?
|
| Disability Evaluation | 4 | 2013 | 1835 | 0.200 |
Why?
|
| Research Design | 2 | 2020 | 6174 | 0.200 |
Why?
|
| Heart Atria | 2 | 2018 | 1333 | 0.200 |
Why?
|
| Mastectomy | 5 | 2013 | 1817 | 0.200 |
Why?
|
| Nursing Diagnosis | 1 | 2021 | 16 | 0.200 |
Why?
|
| Incidence | 15 | 2023 | 21339 | 0.200 |
Why?
|
| Reflex | 1 | 2024 | 375 | 0.200 |
Why?
|
| Indocyanine Green | 4 | 2013 | 233 | 0.190 |
Why?
|
| Swine, Miniature | 1 | 2024 | 961 | 0.190 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2024 | 2292 | 0.190 |
Why?
|
| Heart Failure | 4 | 2022 | 11670 | 0.190 |
Why?
|
| United States | 28 | 2024 | 72292 | 0.190 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2021 | 1081 | 0.190 |
Why?
|
| Pattern Recognition, Automated | 4 | 2012 | 994 | 0.190 |
Why?
|
| Decision Support Techniques | 3 | 2024 | 1999 | 0.190 |
Why?
|
| Healthcare Disparities | 4 | 2024 | 3351 | 0.190 |
Why?
|
| Employment | 2 | 2007 | 1113 | 0.190 |
Why?
|
| Prognosis | 13 | 2024 | 29601 | 0.190 |
Why?
|
| Air Pollutants, Occupational | 3 | 2011 | 407 | 0.180 |
Why?
|
| Aortic Valve Stenosis | 2 | 2024 | 2003 | 0.180 |
Why?
|
| Heart Arrest | 4 | 2019 | 1513 | 0.180 |
Why?
|
| Hypertension | 5 | 2023 | 8532 | 0.180 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2024 | 253 | 0.180 |
Why?
|
| Hydrocarbons | 3 | 2006 | 105 | 0.180 |
Why?
|
| Hospital Mortality | 10 | 2017 | 5292 | 0.180 |
Why?
|
| Endomyocardial Fibrosis | 1 | 2020 | 41 | 0.180 |
Why?
|
| Atrial Function, Left | 2 | 2018 | 183 | 0.180 |
Why?
|
| Double-Blind Method | 8 | 2024 | 12333 | 0.180 |
Why?
|
| Hypotension, Orthostatic | 1 | 2023 | 258 | 0.180 |
Why?
|
| Breast | 2 | 2023 | 1963 | 0.170 |
Why?
|
| Fluorometry | 2 | 2010 | 99 | 0.170 |
Why?
|
| Respiratory Mechanics | 3 | 2012 | 699 | 0.170 |
Why?
|
| Hypoglycemic Agents | 3 | 2022 | 3085 | 0.170 |
Why?
|
| Colonic Polyps | 3 | 2010 | 553 | 0.170 |
Why?
|
| Metabolomics | 3 | 2024 | 1656 | 0.170 |
Why?
|
| Stroke Volume | 8 | 2024 | 5486 | 0.170 |
Why?
|
| Longitudinal Studies | 11 | 2024 | 14599 | 0.170 |
Why?
|
| Health Plan Implementation | 2 | 2021 | 335 | 0.170 |
Why?
|
| HIV Infections | 6 | 2024 | 17342 | 0.170 |
Why?
|
| Colectomy | 1 | 2024 | 686 | 0.170 |
Why?
|
| Young Adult | 22 | 2024 | 59191 | 0.160 |
Why?
|
| Diabetes Mellitus | 5 | 2024 | 5838 | 0.160 |
Why?
|
| Cohort Studies | 25 | 2024 | 41464 | 0.160 |
Why?
|
| Histamine H2 Antagonists | 2 | 2011 | 165 | 0.160 |
Why?
|
| Polyomavirus Infections | 2 | 2011 | 191 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2024 | 3798 | 0.160 |
Why?
|
| Manganese | 2 | 2011 | 393 | 0.160 |
Why?
|
| Proteome | 4 | 2022 | 1857 | 0.160 |
Why?
|
| Health Literacy | 2 | 2022 | 443 | 0.160 |
Why?
|
| Feasibility Studies | 5 | 2024 | 5239 | 0.160 |
Why?
|
| Nursing Staff, Hospital | 2 | 2021 | 348 | 0.150 |
Why?
|
| Liver Neoplasms | 2 | 2024 | 4309 | 0.150 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2019 | 148 | 0.150 |
Why?
|
| Boston | 13 | 2022 | 9313 | 0.150 |
Why?
|
| Blood-Brain Barrier | 2 | 2023 | 1027 | 0.150 |
Why?
|
| Anti-Obesity Agents | 1 | 2021 | 227 | 0.150 |
Why?
|
| Neurofilament Proteins | 1 | 2020 | 333 | 0.150 |
Why?
|
| Blood Flow Velocity | 2 | 2013 | 1369 | 0.150 |
Why?
|
| Heart Rate | 7 | 2022 | 4181 | 0.150 |
Why?
|
| Geriatric Nursing | 1 | 2018 | 39 | 0.150 |
Why?
|
| Patient Education as Topic | 4 | 2016 | 2315 | 0.150 |
Why?
|
| Follow-Up Studies | 12 | 2024 | 39062 | 0.150 |
Why?
|
| Health Facilities | 2 | 2023 | 578 | 0.150 |
Why?
|
| Language | 3 | 2023 | 1541 | 0.150 |
Why?
|
| Communication | 5 | 2022 | 3851 | 0.150 |
Why?
|
| Pilot Projects | 14 | 2024 | 8619 | 0.150 |
Why?
|
| Physician-Patient Relations | 6 | 2024 | 3239 | 0.150 |
Why?
|
| Epistasis, Genetic | 1 | 2020 | 350 | 0.150 |
Why?
|
| Expert Systems | 1 | 1997 | 79 | 0.150 |
Why?
|
| Hypotension | 1 | 2023 | 879 | 0.140 |
Why?
|
| Psychometrics | 3 | 2016 | 3062 | 0.140 |
Why?
|
| Religion | 1 | 2021 | 376 | 0.140 |
Why?
|
| Pulmonary Artery | 2 | 2018 | 1927 | 0.140 |
Why?
|
| Comorbidity | 15 | 2019 | 10507 | 0.140 |
Why?
|
| Nursing Homes | 2 | 2019 | 1083 | 0.140 |
Why?
|
| Focus Groups | 3 | 2022 | 1409 | 0.140 |
Why?
|
| Accidental Falls | 2 | 2023 | 1067 | 0.140 |
Why?
|
| Opioid-Related Disorders | 2 | 2023 | 2164 | 0.140 |
Why?
|
| Ascorbic Acid | 1 | 2020 | 655 | 0.140 |
Why?
|
| Emergency Service, Hospital | 10 | 2014 | 7873 | 0.140 |
Why?
|
| Phantoms, Imaging | 4 | 2019 | 2518 | 0.140 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2018 | 251 | 0.130 |
Why?
|
| Cross Infection | 3 | 2020 | 1422 | 0.130 |
Why?
|
| Extracellular Matrix | 1 | 2024 | 1718 | 0.130 |
Why?
|
| Coloring Agents | 4 | 2013 | 562 | 0.130 |
Why?
|
| Neural Stem Cells | 1 | 2023 | 887 | 0.130 |
Why?
|
| Obesity | 6 | 2021 | 12934 | 0.130 |
Why?
|
| Internet | 6 | 2016 | 3094 | 0.130 |
Why?
|
| Periodontal Index | 2 | 2014 | 151 | 0.130 |
Why?
|
| Inpatients | 3 | 2021 | 2545 | 0.130 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2020 | 6016 | 0.130 |
Why?
|
| Frail Elderly | 2 | 2023 | 765 | 0.130 |
Why?
|
| Occupational Exposure | 6 | 2011 | 1813 | 0.130 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2020 | 1171 | 0.130 |
Why?
|
| Environmental Monitoring | 6 | 2007 | 1460 | 0.130 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2022 | 628 | 0.130 |
Why?
|
| Proportional Hazards Models | 12 | 2024 | 12448 | 0.130 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2022 | 557 | 0.130 |
Why?
|
| Resuscitation | 2 | 2018 | 672 | 0.130 |
Why?
|
| tau Proteins | 2 | 2024 | 2093 | 0.130 |
Why?
|
| Aneurysm, Ruptured | 1 | 2021 | 464 | 0.130 |
Why?
|
| Ambulatory Care | 2 | 2021 | 2768 | 0.130 |
Why?
|
| Physician Assistants | 1 | 2018 | 190 | 0.130 |
Why?
|
| Carcinoma, Renal Cell | 4 | 2013 | 3164 | 0.130 |
Why?
|
| Time | 1 | 1997 | 545 | 0.130 |
Why?
|
| Azo Compounds | 1 | 2015 | 117 | 0.130 |
Why?
|
| Sus scrofa | 4 | 2019 | 428 | 0.130 |
Why?
|
| Audiovisual Aids | 1 | 2016 | 99 | 0.120 |
Why?
|
| Angina Pectoris | 1 | 2019 | 959 | 0.120 |
Why?
|
| Pulmonary Veins | 2 | 2011 | 716 | 0.120 |
Why?
|
| Professional-Patient Relations | 1 | 2020 | 724 | 0.120 |
Why?
|
| Brain | 8 | 2023 | 27100 | 0.120 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 1996 | 146 | 0.120 |
Why?
|
| Rural Health Services | 1 | 2019 | 384 | 0.120 |
Why?
|
| Heart Diseases | 2 | 2019 | 2778 | 0.120 |
Why?
|
| Cross-Sectional Studies | 15 | 2023 | 26065 | 0.120 |
Why?
|
| Gentamicins | 1 | 1996 | 243 | 0.120 |
Why?
|
| Zirconium | 1 | 2015 | 108 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 4 | 2017 | 558 | 0.120 |
Why?
|
| Benchmarking | 1 | 2021 | 1045 | 0.120 |
Why?
|
| Proton Pump Inhibitors | 2 | 2011 | 533 | 0.120 |
Why?
|
| Apolipoprotein E4 | 2 | 2020 | 709 | 0.120 |
Why?
|
| Artifacts | 3 | 2012 | 1910 | 0.120 |
Why?
|
| Time Factors | 17 | 2024 | 39908 | 0.120 |
Why?
|
| Apolipoprotein E2 | 1 | 2015 | 135 | 0.120 |
Why?
|
| Information Storage and Retrieval | 3 | 2005 | 819 | 0.120 |
Why?
|
| Sarcoidosis | 1 | 2020 | 520 | 0.120 |
Why?
|
| Mitral Valve Prolapse | 1 | 2016 | 212 | 0.120 |
Why?
|
| Health Status | 3 | 2007 | 4076 | 0.120 |
Why?
|
| Information Seeking Behavior | 1 | 2016 | 116 | 0.120 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2013 | 1116 | 0.120 |
Why?
|
| Exercise Test | 2 | 2019 | 2127 | 0.120 |
Why?
|
| Endothelial Cells | 3 | 2023 | 3550 | 0.120 |
Why?
|
| Benzoates | 1 | 2015 | 212 | 0.110 |
Why?
|
| Respiratory Function Tests | 8 | 2007 | 1683 | 0.110 |
Why?
|
| Adipose Tissue | 3 | 2018 | 3310 | 0.110 |
Why?
|
| Electronic Mail | 1 | 2016 | 213 | 0.110 |
Why?
|
| Kidney Cortex Necrosis | 1 | 2013 | 6 | 0.110 |
Why?
|
| Kidney Neoplasms | 4 | 2013 | 4252 | 0.110 |
Why?
|
| Apolipoproteins E | 1 | 2020 | 1443 | 0.110 |
Why?
|
| Community Health Services | 1 | 2019 | 654 | 0.110 |
Why?
|
| Appointments and Schedules | 1 | 2018 | 442 | 0.110 |
Why?
|
| Microcirculation | 1 | 2018 | 1272 | 0.110 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2016 | 1493 | 0.110 |
Why?
|
| Heart Conduction System | 1 | 2019 | 992 | 0.110 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2011 | 926 | 0.110 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2016 | 266 | 0.110 |
Why?
|
| Shock | 1 | 2016 | 314 | 0.110 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2011 | 619 | 0.110 |
Why?
|
| Pericardium | 1 | 2018 | 664 | 0.110 |
Why?
|
| Adolescent | 24 | 2024 | 88247 | 0.110 |
Why?
|
| Consumer Health Information | 1 | 2016 | 215 | 0.110 |
Why?
|
| Analysis of Variance | 7 | 2012 | 6223 | 0.110 |
Why?
|
| Kidney | 5 | 2023 | 7044 | 0.110 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2009 | 556 | 0.110 |
Why?
|
| Amides | 1 | 2015 | 449 | 0.110 |
Why?
|
| Interview, Psychological | 1 | 2016 | 809 | 0.110 |
Why?
|
| Dysmenorrhea | 2 | 2024 | 94 | 0.100 |
Why?
|
| Affect | 1 | 2020 | 1486 | 0.100 |
Why?
|
| Antacids | 1 | 2013 | 94 | 0.100 |
Why?
|
| Body Surface Potential Mapping | 1 | 2014 | 223 | 0.100 |
Why?
|
| Drug Utilization | 3 | 2013 | 1186 | 0.100 |
Why?
|
| Amyloid beta-Peptides | 2 | 2024 | 3839 | 0.100 |
Why?
|
| Vasoconstrictor Agents | 1 | 2016 | 654 | 0.100 |
Why?
|
| Probability Learning | 1 | 2012 | 23 | 0.100 |
Why?
|
| California | 11 | 2006 | 1431 | 0.100 |
Why?
|
| Vietnam | 3 | 2019 | 406 | 0.100 |
Why?
|
| Hypokinesia | 1 | 2011 | 23 | 0.100 |
Why?
|
| Myocardial Infarction | 4 | 2019 | 11458 | 0.100 |
Why?
|
| Overweight | 2 | 2021 | 2417 | 0.100 |
Why?
|
| Disease Models, Animal | 6 | 2024 | 18220 | 0.100 |
Why?
|
| Environmental Exposure | 5 | 2012 | 4483 | 0.100 |
Why?
|
| Diagnosis, Differential | 6 | 2021 | 12966 | 0.100 |
Why?
|
| Seizures | 2 | 2015 | 2964 | 0.100 |
Why?
|
| Hospital Rapid Response Team | 1 | 2012 | 54 | 0.100 |
Why?
|
| Health Services Research | 2 | 2018 | 1808 | 0.100 |
Why?
|
| Inflammation | 4 | 2024 | 10759 | 0.100 |
Why?
|
| Virus Activation | 2 | 2014 | 319 | 0.100 |
Why?
|
| Patient Satisfaction | 2 | 2016 | 3451 | 0.100 |
Why?
|
| HIV | 1 | 2019 | 1580 | 0.100 |
Why?
|
| Cognition Disorders | 2 | 2016 | 3979 | 0.100 |
Why?
|
| Atrial Fibrillation | 4 | 2018 | 5031 | 0.100 |
Why?
|
| Action Potentials | 1 | 2019 | 1825 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 2270 | 0.100 |
Why?
|
| Colon | 2 | 2010 | 1791 | 0.100 |
Why?
|
| Office Visits | 1 | 2016 | 593 | 0.090 |
Why?
|
| Viral Load | 2 | 2019 | 3325 | 0.090 |
Why?
|
| Pseudomonas Infections | 1 | 1996 | 621 | 0.090 |
Why?
|
| Radiography, Thoracic | 2 | 2020 | 1302 | 0.090 |
Why?
|
| Disease Progression | 7 | 2020 | 13495 | 0.090 |
Why?
|
| Hydrocortisone | 2 | 2016 | 1819 | 0.090 |
Why?
|
| Wavelet Analysis | 1 | 2011 | 55 | 0.090 |
Why?
|
| SEER Program | 7 | 2011 | 1450 | 0.090 |
Why?
|
| Socioeconomic Factors | 5 | 2022 | 7805 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 1878 | 0.090 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2024 | 2118 | 0.090 |
Why?
|
| Critical Illness | 3 | 2012 | 2709 | 0.090 |
Why?
|
| Fucose | 1 | 2011 | 122 | 0.090 |
Why?
|
| ROC Curve | 4 | 2020 | 3575 | 0.090 |
Why?
|
| Acute Kidney Injury | 1 | 2023 | 1923 | 0.090 |
Why?
|
| Embolization, Therapeutic | 1 | 2021 | 1418 | 0.090 |
Why?
|
| Nipples | 1 | 2013 | 229 | 0.090 |
Why?
|
| Intracranial Aneurysm | 1 | 2021 | 1285 | 0.090 |
Why?
|
| Angiomyolipoma | 1 | 2012 | 188 | 0.090 |
Why?
|
| Prostatic Neoplasms | 5 | 2013 | 11107 | 0.090 |
Why?
|
| Dizziness | 1 | 2014 | 259 | 0.090 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2012 | 217 | 0.090 |
Why?
|
| Air Pollutants | 4 | 2011 | 2893 | 0.090 |
Why?
|
| Welding | 1 | 2011 | 89 | 0.090 |
Why?
|
| Construction Materials | 3 | 2006 | 60 | 0.090 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2023 | 1551 | 0.090 |
Why?
|
| Pain | 2 | 2021 | 5062 | 0.090 |
Why?
|
| Multivariate Analysis | 7 | 2017 | 12043 | 0.090 |
Why?
|
| Stochastic Processes | 1 | 2012 | 355 | 0.090 |
Why?
|
| Coronary Disease | 2 | 2023 | 5911 | 0.090 |
Why?
|
| Periodontitis | 1 | 2015 | 568 | 0.090 |
Why?
|
| Lactic Acid | 1 | 2016 | 1139 | 0.090 |
Why?
|
| Executive Function | 1 | 2019 | 1391 | 0.090 |
Why?
|
| Air Pollution | 5 | 2012 | 2355 | 0.090 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2014 | 474 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2017 | 2703 | 0.090 |
Why?
|
| Air | 1 | 2010 | 187 | 0.090 |
Why?
|
| Isosorbide Dinitrate | 1 | 2010 | 34 | 0.090 |
Why?
|
| Memory | 1 | 2020 | 2192 | 0.090 |
Why?
|
| Electric Countershock | 1 | 2013 | 532 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2020 | 20556 | 0.090 |
Why?
|
| Social Security | 2 | 2007 | 101 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2013 | 6473 | 0.090 |
Why?
|
| Fibrosis | 3 | 2024 | 2047 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2024 | 3769 | 0.080 |
Why?
|
| Mental Recall | 1 | 2016 | 1222 | 0.080 |
Why?
|
| Blood Glucose | 2 | 2022 | 6390 | 0.080 |
Why?
|
| Integrin alpha4 | 1 | 2009 | 87 | 0.080 |
Why?
|
| Cerebellar Diseases | 1 | 2011 | 220 | 0.080 |
Why?
|
| Rectal Diseases | 1 | 2010 | 142 | 0.080 |
Why?
|
| Nonlinear Dynamics | 1 | 2012 | 491 | 0.080 |
Why?
|
| Radiation Protection | 1 | 2013 | 424 | 0.080 |
Why?
|
| Survivors | 2 | 2020 | 2373 | 0.080 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1990 | 350 | 0.080 |
Why?
|
| Odds Ratio | 4 | 2015 | 9644 | 0.080 |
Why?
|
| Urban Health Services | 1 | 2010 | 176 | 0.080 |
Why?
|
| DNA Damage | 3 | 2010 | 2445 | 0.080 |
Why?
|
| Computer Simulation | 4 | 2010 | 6233 | 0.080 |
Why?
|
| Ebolavirus | 1 | 2011 | 251 | 0.080 |
Why?
|
| Pneumonia | 2 | 2012 | 2143 | 0.080 |
Why?
|
| Tachycardia, Ventricular | 1 | 2017 | 1261 | 0.080 |
Why?
|
| Linear Models | 7 | 2016 | 5866 | 0.080 |
Why?
|
| Parkinsonian Disorders | 1 | 2011 | 285 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2017 | 8998 | 0.080 |
Why?
|
| Protein C | 1 | 2009 | 133 | 0.080 |
Why?
|
| Pyrenes | 2 | 2007 | 49 | 0.080 |
Why?
|
| Interviews as Topic | 3 | 2015 | 2697 | 0.080 |
Why?
|
| Intensive Care Units | 4 | 2016 | 3743 | 0.080 |
Why?
|
| Emergency Treatment | 3 | 2007 | 495 | 0.080 |
Why?
|
| Depression | 2 | 2022 | 8132 | 0.080 |
Why?
|
| Terminology as Topic | 2 | 2006 | 1528 | 0.080 |
Why?
|
| Capsid Proteins | 1 | 2011 | 464 | 0.080 |
Why?
|
| Artificial Intelligence | 4 | 2012 | 2575 | 0.080 |
Why?
|
| Prospective Payment System | 1 | 2009 | 135 | 0.080 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1996 | 1272 | 0.080 |
Why?
|
| Interleukin-1 | 2 | 2009 | 1248 | 0.080 |
Why?
|
| Drug Prescriptions | 2 | 2024 | 1669 | 0.070 |
Why?
|
| Lipocalins | 1 | 2009 | 161 | 0.070 |
Why?
|
| Inhalation Exposure | 3 | 2006 | 432 | 0.070 |
Why?
|
| Biopsy, Needle | 1 | 2013 | 1624 | 0.070 |
Why?
|
| Tachycardia, Supraventricular | 1 | 1990 | 266 | 0.070 |
Why?
|
| Mortality | 3 | 2016 | 2899 | 0.070 |
Why?
|
| Phenotype | 2 | 2023 | 16572 | 0.070 |
Why?
|
| Information Dissemination | 1 | 2016 | 1126 | 0.070 |
Why?
|
| Preoperative Care | 2 | 2016 | 2242 | 0.070 |
Why?
|
| Atherosclerosis | 1 | 2023 | 3400 | 0.070 |
Why?
|
| Internationality | 1 | 2013 | 1000 | 0.070 |
Why?
|
| Health Services for the Aged | 1 | 2010 | 258 | 0.070 |
Why?
|
| Hydroxamic Acids | 1 | 2010 | 481 | 0.070 |
Why?
|
| Virus Latency | 1 | 2010 | 354 | 0.070 |
Why?
|
| Quality of Life | 3 | 2023 | 13359 | 0.070 |
Why?
|
| Academic Medical Centers | 4 | 2013 | 2756 | 0.070 |
Why?
|
| Pulmonary Medicine | 1 | 2009 | 221 | 0.070 |
Why?
|
| Sodium Radioisotopes | 1 | 2006 | 6 | 0.070 |
Why?
|
| Patient-Centered Care | 1 | 2017 | 1419 | 0.070 |
Why?
|
| Data Mining | 1 | 2012 | 551 | 0.070 |
Why?
|
| Sequence Deletion | 1 | 2011 | 1490 | 0.070 |
Why?
|
| Treatment Outcome | 13 | 2024 | 64572 | 0.070 |
Why?
|
| Occupational Health Services | 1 | 2008 | 150 | 0.070 |
Why?
|
| Length of Stay | 6 | 2021 | 6418 | 0.070 |
Why?
|
| Telephone | 2 | 2009 | 626 | 0.070 |
Why?
|
| Aorta, Thoracic | 1 | 2013 | 1096 | 0.070 |
Why?
|
| Patient Admission | 2 | 2012 | 1365 | 0.070 |
Why?
|
| Endovascular Procedures | 1 | 2021 | 2182 | 0.070 |
Why?
|
| Cognition | 6 | 2023 | 6988 | 0.070 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2012 | 709 | 0.070 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2017 | 2400 | 0.070 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2009 | 240 | 0.070 |
Why?
|
| Health Services Accessibility | 2 | 2019 | 5430 | 0.070 |
Why?
|
| Carcinoma, Lobular | 1 | 2011 | 480 | 0.070 |
Why?
|
| Lymphatic Vessels | 1 | 2011 | 356 | 0.070 |
Why?
|
| Age Factors | 7 | 2015 | 18381 | 0.070 |
Why?
|
| Budgets | 1 | 2008 | 230 | 0.070 |
Why?
|
| DNA, Viral | 2 | 2010 | 2194 | 0.070 |
Why?
|
| Veins | 1 | 2010 | 767 | 0.070 |
Why?
|
| Muscular Diseases | 1 | 2011 | 552 | 0.070 |
Why?
|
| DNA Adducts | 1 | 2006 | 94 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2021 | 11512 | 0.070 |
Why?
|
| Antipsychotic Agents | 1 | 2019 | 3067 | 0.070 |
Why?
|
| Vaginal Creams, Foams, and Jellies | 1 | 2006 | 62 | 0.070 |
Why?
|
| Blood Pressure | 4 | 2023 | 8473 | 0.070 |
Why?
|
| Clinical Competence | 3 | 2018 | 4790 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2016 | 2597 | 0.070 |
Why?
|
| Body Mass Index | 6 | 2021 | 12942 | 0.060 |
Why?
|
| Bronchiolitis | 1 | 2012 | 485 | 0.060 |
Why?
|
| Health Care Surveys | 1 | 2013 | 2422 | 0.060 |
Why?
|
| Anticonvulsants | 1 | 2015 | 1910 | 0.060 |
Why?
|
| Editorial Policies | 3 | 2018 | 458 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 1 | 2016 | 2726 | 0.060 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 973 | 0.060 |
Why?
|
| Attitude to Health | 1 | 2014 | 2025 | 0.060 |
Why?
|
| Subtraction Technique | 1 | 2008 | 512 | 0.060 |
Why?
|
| Catheter Ablation | 1 | 2018 | 2634 | 0.060 |
Why?
|
| Heart Ventricles | 1 | 2017 | 3796 | 0.060 |
Why?
|
| Swine | 4 | 2024 | 5908 | 0.060 |
Why?
|
| Mastectomy, Segmental | 2 | 2010 | 955 | 0.060 |
Why?
|
| Hospitals | 2 | 2021 | 3879 | 0.060 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2010 | 774 | 0.060 |
Why?
|
| Eligibility Determination | 1 | 2009 | 421 | 0.060 |
Why?
|
| Vocabulary | 1 | 2006 | 166 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2017 | 3492 | 0.060 |
Why?
|
| Medical Order Entry Systems | 1 | 2010 | 521 | 0.060 |
Why?
|
| Lung Diseases | 2 | 2019 | 1909 | 0.060 |
Why?
|
| Pennsylvania | 2 | 2019 | 612 | 0.060 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5334 | 0.060 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 3196 | 0.060 |
Why?
|
| Regression Analysis | 6 | 2015 | 6339 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2011 | 3245 | 0.060 |
Why?
|
| Critical Care | 2 | 2021 | 2691 | 0.060 |
Why?
|
| Radiation Dosage | 1 | 2013 | 1956 | 0.060 |
Why?
|
| Financing, Government | 1 | 2008 | 472 | 0.060 |
Why?
|
| Physical Therapy Modalities | 1 | 2008 | 530 | 0.060 |
Why?
|
| Word Processing | 1 | 2004 | 7 | 0.060 |
Why?
|
| Echo-Planar Imaging | 1 | 2008 | 663 | 0.060 |
Why?
|
| Automation | 1 | 2007 | 585 | 0.060 |
Why?
|
| Medication Errors | 1 | 2010 | 783 | 0.060 |
Why?
|
| Electrocardiography | 5 | 2019 | 6346 | 0.060 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2789 | 0.060 |
Why?
|
| Lymph Nodes | 3 | 2011 | 3461 | 0.060 |
Why?
|
| Pregnancy | 4 | 2023 | 29869 | 0.060 |
Why?
|
| MEDLINE | 1 | 2004 | 119 | 0.060 |
Why?
|
| Deoxyguanosine | 1 | 2004 | 92 | 0.060 |
Why?
|
| Bayes Theorem | 4 | 2011 | 2327 | 0.060 |
Why?
|
| Hazardous Substances | 2 | 2002 | 153 | 0.060 |
Why?
|
| Kidney Diseases | 2 | 2011 | 2090 | 0.060 |
Why?
|
| User-Computer Interface | 2 | 2007 | 1397 | 0.060 |
Why?
|
| Medication Adherence | 1 | 2015 | 2175 | 0.060 |
Why?
|
| Mutagens | 1 | 2004 | 179 | 0.060 |
Why?
|
| Blood Pressure Determination | 2 | 2023 | 633 | 0.060 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2006 | 247 | 0.060 |
Why?
|
| Language Tests | 1 | 2004 | 190 | 0.060 |
Why?
|
| Hip Fractures | 2 | 2010 | 988 | 0.050 |
Why?
|
| Arthritis | 1 | 2009 | 680 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2007 | 4010 | 0.050 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2011 | 1084 | 0.050 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 2023 | 72 | 0.050 |
Why?
|
| Neoplasm Staging | 8 | 2011 | 11118 | 0.050 |
Why?
|
| Mental Status Schedule | 1 | 2004 | 315 | 0.050 |
Why?
|
| Natural Language Processing | 1 | 2012 | 1166 | 0.050 |
Why?
|
| Laryngeal Muscles | 1 | 2024 | 107 | 0.050 |
Why?
|
| Body Composition | 2 | 2023 | 2426 | 0.050 |
Why?
|
| DNA Repair | 2 | 2010 | 2043 | 0.050 |
Why?
|
| Health Status Indicators | 2 | 2006 | 970 | 0.050 |
Why?
|
| Probability | 3 | 2023 | 2475 | 0.050 |
Why?
|
| Family | 3 | 2024 | 3193 | 0.050 |
Why?
|
| Patient Readmission | 3 | 2024 | 3269 | 0.050 |
Why?
|
| Prejudice | 1 | 2007 | 571 | 0.050 |
Why?
|
| Dementia, Vascular | 1 | 2004 | 122 | 0.050 |
Why?
|
| Smoking | 4 | 2012 | 9054 | 0.050 |
Why?
|
| Anti-HIV Agents | 1 | 2019 | 4524 | 0.050 |
Why?
|
| Carotid Arteries | 1 | 2007 | 941 | 0.050 |
Why?
|
| Speech Disorders | 1 | 2004 | 180 | 0.050 |
Why?
|
| Movement Disorders | 1 | 2006 | 459 | 0.050 |
Why?
|
| Social Class | 1 | 2011 | 1993 | 0.050 |
Why?
|
| Statistics, Nonparametric | 4 | 2012 | 2851 | 0.050 |
Why?
|
| British Columbia | 1 | 2022 | 241 | 0.050 |
Why?
|
| Health Surveys | 4 | 2007 | 4036 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2011 | 4365 | 0.050 |
Why?
|
| Vehicle Emissions | 1 | 2007 | 655 | 0.050 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2011 | 1723 | 0.050 |
Why?
|
| Neurodegenerative Diseases | 1 | 2011 | 1085 | 0.050 |
Why?
|
| Hospitals, Urban | 3 | 2009 | 500 | 0.050 |
Why?
|
| Demography | 1 | 2007 | 1643 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 2689 | 0.050 |
Why?
|
| Prevalence | 7 | 2019 | 15702 | 0.050 |
Why?
|
| Educational Status | 4 | 2016 | 2509 | 0.050 |
Why?
|
| Surgical Flaps | 1 | 2010 | 1670 | 0.050 |
Why?
|
| Muscle, Skeletal | 2 | 2011 | 4947 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2024 | 10203 | 0.050 |
Why?
|
| Coronary Artery Disease | 2 | 2019 | 6403 | 0.050 |
Why?
|
| Quantum Theory | 1 | 2001 | 69 | 0.050 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2023 | 244 | 0.050 |
Why?
|
| Sodium | 1 | 2006 | 1588 | 0.050 |
Why?
|
| Liver Cirrhosis | 1 | 2011 | 1927 | 0.050 |
Why?
|
| Principal Component Analysis | 1 | 2024 | 943 | 0.050 |
Why?
|
| Lamin Type A | 1 | 2022 | 186 | 0.050 |
Why?
|
| Area Under Curve | 2 | 2020 | 1635 | 0.050 |
Why?
|
| Massachusetts | 4 | 2019 | 8835 | 0.050 |
Why?
|
| Ventricular Remodeling | 2 | 2019 | 1265 | 0.050 |
Why?
|
| Hemodynamics | 4 | 2018 | 4160 | 0.040 |
Why?
|
| Syncope | 1 | 2023 | 428 | 0.040 |
Why?
|
| Mammaplasty | 1 | 2010 | 1232 | 0.040 |
Why?
|
| Anxiety | 2 | 2014 | 4573 | 0.040 |
Why?
|
| Musculoskeletal Diseases | 1 | 2006 | 597 | 0.040 |
Why?
|
| Carbon | 1 | 2004 | 665 | 0.040 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2001 | 302 | 0.040 |
Why?
|
| Oligonucleotides | 1 | 2023 | 566 | 0.040 |
Why?
|
| Animals | 16 | 2024 | 168202 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2008 | 1397 | 0.040 |
Why?
|
| Treatment Failure | 2 | 2020 | 2635 | 0.040 |
Why?
|
| Selection Bias | 1 | 2022 | 359 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2024 | 678 | 0.040 |
Why?
|
| Reference Standards | 1 | 2023 | 1003 | 0.040 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2006 | 661 | 0.040 |
Why?
|
| Hypernatremia | 1 | 2020 | 78 | 0.040 |
Why?
|
| Vaginal Smears | 1 | 2003 | 499 | 0.040 |
Why?
|
| Coronary Artery Bypass | 3 | 1999 | 2188 | 0.040 |
Why?
|
| Emotions | 2 | 2023 | 2741 | 0.040 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2022 | 256 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2023 | 1336 | 0.040 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 2011 | 277 | 0.040 |
Why?
|
| Phenylalanine-tRNA Ligase | 1 | 1999 | 15 | 0.040 |
Why?
|
| Cooperative Behavior | 1 | 2007 | 1505 | 0.040 |
Why?
|
| Brachytherapy | 1 | 2007 | 1223 | 0.040 |
Why?
|
| Tennessee | 1 | 2019 | 119 | 0.040 |
Why?
|
| Menopause | 1 | 2007 | 1645 | 0.040 |
Why?
|
| Drug Therapy | 1 | 2002 | 503 | 0.040 |
Why?
|
| Hand Strength | 1 | 2002 | 456 | 0.040 |
Why?
|
| Motion | 2 | 2013 | 779 | 0.040 |
Why?
|
| Stroke | 2 | 2014 | 9715 | 0.040 |
Why?
|
| England | 1 | 2020 | 526 | 0.040 |
Why?
|
| Biopsy | 3 | 2024 | 6763 | 0.040 |
Why?
|
| Child, Preschool | 6 | 2024 | 42193 | 0.040 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 1999 | 86 | 0.040 |
Why?
|
| Appendicitis | 1 | 2006 | 675 | 0.040 |
Why?
|
| Intraoperative Period | 2 | 2010 | 510 | 0.040 |
Why?
|
| Risk | 4 | 2015 | 9603 | 0.040 |
Why?
|
| Supine Position | 1 | 2019 | 205 | 0.040 |
Why?
|
| Electromyography | 1 | 2024 | 1392 | 0.040 |
Why?
|
| Thinness | 1 | 2002 | 480 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 3 | 2010 | 1784 | 0.040 |
Why?
|
| Dental Caries | 1 | 2003 | 427 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 4433 | 0.040 |
Why?
|
| Seasons | 3 | 2012 | 1518 | 0.040 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2020 | 550 | 0.040 |
Why?
|
| Plasma | 1 | 2022 | 586 | 0.040 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2001 | 509 | 0.040 |
Why?
|
| Proteins | 2 | 2012 | 6030 | 0.040 |
Why?
|
| Health Services | 1 | 2004 | 751 | 0.040 |
Why?
|
| Leukocytes | 1 | 2006 | 2024 | 0.040 |
Why?
|
| Fatty Liver | 1 | 2024 | 787 | 0.040 |
Why?
|
| Thrombolytic Therapy | 1 | 2007 | 2055 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2007 | 1589 | 0.040 |
Why?
|
| Diet, Reducing | 1 | 2021 | 485 | 0.040 |
Why?
|
| Canada | 1 | 2023 | 2120 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2011 | 691 | 0.040 |
Why?
|
| Models, Theoretical | 2 | 2007 | 3567 | 0.040 |
Why?
|
| Tissue Survival | 1 | 2018 | 119 | 0.040 |
Why?
|
| Hospitals, University | 2 | 2012 | 565 | 0.040 |
Why?
|
| Intracranial Hemorrhages | 1 | 2023 | 809 | 0.040 |
Why?
|
| Preventive Health Services | 1 | 2003 | 566 | 0.040 |
Why?
|
| Myositis Ossificans | 1 | 1999 | 77 | 0.040 |
Why?
|
| Chi-Square Distribution | 3 | 2012 | 3410 | 0.040 |
Why?
|
| Magnesium | 1 | 2001 | 804 | 0.040 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2001 | 820 | 0.040 |
Why?
|
| Hyperglycemia | 2 | 2020 | 1375 | 0.040 |
Why?
|
| Neuroglia | 1 | 2023 | 954 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 5776 | 0.040 |
Why?
|
| Respiration | 2 | 2013 | 1656 | 0.040 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2011 | 3204 | 0.040 |
Why?
|
| Creatinine | 1 | 2023 | 1895 | 0.040 |
Why?
|
| Fluorescence | 2 | 2011 | 756 | 0.040 |
Why?
|
| Logic | 1 | 1997 | 40 | 0.040 |
Why?
|
| Child | 5 | 2024 | 80089 | 0.040 |
Why?
|
| Communicable Diseases | 1 | 2006 | 871 | 0.040 |
Why?
|
| Insurance, Health | 2 | 2007 | 2495 | 0.040 |
Why?
|
| Survival Rate | 5 | 2016 | 12719 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 1996 | 7403 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2011 | 4570 | 0.040 |
Why?
|
| Databases, Factual | 3 | 2021 | 7963 | 0.040 |
Why?
|
| Qualitative Research | 2 | 2021 | 3017 | 0.040 |
Why?
|
| Homes for the Aged | 1 | 2019 | 273 | 0.030 |
Why?
|
| Statistics as Topic | 2 | 2017 | 2358 | 0.030 |
Why?
|
| Acute Disease | 3 | 2012 | 7236 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2023 | 1070 | 0.030 |
Why?
|
| Cysteine | 1 | 2021 | 891 | 0.030 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2001 | 365 | 0.030 |
Why?
|
| Urine | 2 | 2009 | 362 | 0.030 |
Why?
|
| Aging | 3 | 2021 | 8700 | 0.030 |
Why?
|
| Physical Fitness | 2 | 1998 | 743 | 0.030 |
Why?
|
| Air Pollution, Indoor | 1 | 2004 | 900 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 17878 | 0.030 |
Why?
|
| Patient Positioning | 1 | 2019 | 326 | 0.030 |
Why?
|
| Interleukin-6 | 2 | 2022 | 3205 | 0.030 |
Why?
|
| Motor Activity | 1 | 2006 | 2714 | 0.030 |
Why?
|
| Alleles | 2 | 2020 | 6861 | 0.030 |
Why?
|
| Thrombomodulin | 1 | 2017 | 105 | 0.030 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2019 | 480 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2009 | 4512 | 0.030 |
Why?
|
| Documentation | 1 | 2022 | 896 | 0.030 |
Why?
|
| Eating | 1 | 2023 | 1535 | 0.030 |
Why?
|
| Patient Care | 1 | 2022 | 621 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2011 | 9171 | 0.030 |
Why?
|
| Fractures, Bone | 1 | 2008 | 2045 | 0.030 |
Why?
|
| Chloroplasts | 1 | 1996 | 46 | 0.030 |
Why?
|
| Catecholamines | 1 | 1997 | 387 | 0.030 |
Why?
|
| Radionuclide Imaging | 2 | 2011 | 1972 | 0.030 |
Why?
|
| San Francisco | 1 | 1996 | 162 | 0.030 |
Why?
|
| Angiopoietin-2 | 1 | 2017 | 172 | 0.030 |
Why?
|
| Aftercare | 1 | 2022 | 913 | 0.030 |
Why?
|
| Collagen | 1 | 2024 | 2634 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2014 | 5671 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2006 | 2218 | 0.030 |
Why?
|
| Proton-Translocating ATPases | 1 | 1996 | 112 | 0.030 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2011 | 732 | 0.030 |
Why?
|
| Morbidity | 1 | 2021 | 1750 | 0.030 |
Why?
|
| Poisoning | 1 | 1997 | 252 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2019 | 2567 | 0.030 |
Why?
|
| Medical Illustration | 1 | 2016 | 135 | 0.030 |
Why?
|
| Therapy, Computer-Assisted | 1 | 1997 | 266 | 0.030 |
Why?
|
| Benzodiazepines | 1 | 2021 | 1133 | 0.030 |
Why?
|
| Exercise | 2 | 2011 | 5886 | 0.030 |
Why?
|
| Thrombophlebitis | 1 | 1996 | 289 | 0.030 |
Why?
|
| Normal Distribution | 2 | 2011 | 272 | 0.030 |
Why?
|
| Walking | 1 | 2002 | 1197 | 0.030 |
Why?
|
| Permeability | 1 | 2017 | 721 | 0.030 |
Why?
|
| Molecular Sequence Data | 5 | 2011 | 17630 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2020 | 1700 | 0.030 |
Why?
|
| Furans | 1 | 2015 | 202 | 0.030 |
Why?
|
| Skin Absorption | 2 | 2004 | 94 | 0.030 |
Why?
|
| Health Behavior | 1 | 2006 | 2643 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 1068 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2020 | 1892 | 0.030 |
Why?
|
| Lung | 3 | 1998 | 9999 | 0.030 |
Why?
|
| Nitric Acid | 1 | 1993 | 10 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2019 | 1185 | 0.030 |
Why?
|
| Infant | 5 | 2012 | 36157 | 0.030 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2014 | 119 | 0.030 |
Why?
|
| Hemostasis | 1 | 2017 | 469 | 0.030 |
Why?
|
| Forecasting | 2 | 2009 | 2924 | 0.030 |
Why?
|
| Subacute Care | 1 | 2016 | 179 | 0.030 |
Why?
|
| Catalysis | 1 | 2015 | 773 | 0.030 |
Why?
|
| Survival Analysis | 4 | 2012 | 10072 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 2019 | 1515 | 0.030 |
Why?
|
| Gingivitis | 1 | 2014 | 124 | 0.030 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2019 | 575 | 0.030 |
Why?
|
| Neoplasms | 4 | 2019 | 22131 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2012 | 26183 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2021 | 2189 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2018 | 1812 | 0.030 |
Why?
|
| Life Expectancy | 2 | 2011 | 1242 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 2024 | 1737 | 0.030 |
Why?
|
| Renal Veins | 1 | 2013 | 102 | 0.030 |
Why?
|
| Monitoring, Physiologic | 2 | 1999 | 1780 | 0.030 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2021 | 1033 | 0.030 |
Why?
|
| Genotype | 2 | 2020 | 12977 | 0.030 |
Why?
|
| Vasculitis | 1 | 1997 | 522 | 0.030 |
Why?
|
| Drug Resistance, Microbial | 1 | 1996 | 825 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2004 | 3115 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 2017 | 676 | 0.030 |
Why?
|
| Health Resources | 1 | 2019 | 934 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2008 | 5319 | 0.030 |
Why?
|
| Information Services | 2 | 2004 | 236 | 0.030 |
Why?
|
| Methylene Blue | 1 | 2013 | 155 | 0.030 |
Why?
|
| Software | 2 | 1997 | 4432 | 0.030 |
Why?
|
| Reference Values | 2 | 2016 | 4919 | 0.030 |
Why?
|
| Recurrence | 2 | 2018 | 8426 | 0.030 |
Why?
|
| Journal Impact Factor | 1 | 2013 | 153 | 0.030 |
Why?
|
| Laparoscopy | 1 | 2024 | 2030 | 0.020 |
Why?
|
| Lymphatic Metastasis | 2 | 2011 | 2913 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2024 | 9310 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2020 | 1882 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2016 | 1575 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2013 | 573 | 0.020 |
Why?
|
| Perfusion Imaging | 1 | 2013 | 196 | 0.020 |
Why?
|
| Genes, ras | 1 | 1994 | 654 | 0.020 |
Why?
|
| Washington | 1 | 2012 | 315 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2014 | 957 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2006 | 2948 | 0.020 |
Why?
|
| Down-Regulation | 1 | 1999 | 2916 | 0.020 |
Why?
|
| Confined Spaces | 1 | 2011 | 10 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 1998 | 1866 | 0.020 |
Why?
|
| Manganese Poisoning | 1 | 2011 | 13 | 0.020 |
Why?
|
| Health | 2 | 2005 | 398 | 0.020 |
Why?
|
| Complement C1q | 1 | 2011 | 93 | 0.020 |
Why?
|
| Geography | 1 | 2013 | 652 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2015 | 1878 | 0.020 |
Why?
|
| Sequence Alignment | 2 | 2011 | 2178 | 0.020 |
Why?
|
| Phosphorus Isotopes | 1 | 2011 | 124 | 0.020 |
Why?
|
| Propofol | 1 | 1997 | 602 | 0.020 |
Why?
|
| Ohio | 1 | 2011 | 322 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2017 | 1163 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2011 | 269 | 0.020 |
Why?
|
| Semantics | 2 | 2005 | 612 | 0.020 |
Why?
|
| Sex Factors | 3 | 2013 | 10549 | 0.020 |
Why?
|
| Foreskin | 1 | 2010 | 33 | 0.020 |
Why?
|
| Pharmaceutical Preparations | 1 | 2019 | 1086 | 0.020 |
Why?
|
| Urban Population | 2 | 2010 | 2034 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2010 | 3514 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 2011 | 368 | 0.020 |
Why?
|
| Peer Review, Research | 1 | 2013 | 339 | 0.020 |
Why?
|
| Radiopharmaceuticals | 2 | 2011 | 2650 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2010 | 13635 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 6305 | 0.020 |
Why?
|
| Encephalitis | 1 | 2014 | 438 | 0.020 |
Why?
|
| Administration, Sublingual | 1 | 2010 | 59 | 0.020 |
Why?
|
| Pain Measurement | 2 | 2013 | 3546 | 0.020 |
Why?
|
| Weight Loss | 1 | 2021 | 2682 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2013 | 997 | 0.020 |
Why?
|
| New York | 1 | 2012 | 875 | 0.020 |
Why?
|
| Amino Acid Sequence | 4 | 2011 | 13442 | 0.020 |
Why?
|
| Family Relations | 1 | 2012 | 315 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1990 | 861 | 0.020 |
Why?
|
| Atrophy | 1 | 2015 | 1632 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1994 | 1597 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 1995 | 750 | 0.020 |
Why?
|
| Organ Size | 1 | 2015 | 2252 | 0.020 |
Why?
|
| Technetium Tc 99m Sulfur Colloid | 1 | 2009 | 63 | 0.020 |
Why?
|
| Cyclins | 1 | 1992 | 594 | 0.020 |
Why?
|
| Body Weight | 2 | 2015 | 4615 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 8516 | 0.020 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 1992 | 574 | 0.020 |
Why?
|
| Privacy | 1 | 2011 | 233 | 0.020 |
Why?
|
| Patient Selection | 2 | 2013 | 4237 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2011 | 616 | 0.020 |
Why?
|
| Hospital Departments | 1 | 2009 | 134 | 0.020 |
Why?
|
| Infrared Rays | 1 | 2010 | 247 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 1995 | 981 | 0.020 |
Why?
|
| Anti-Retroviral Agents | 1 | 2019 | 1783 | 0.020 |
Why?
|
| Poverty | 2 | 2012 | 2692 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 1997 | 1178 | 0.020 |
Why?
|
| Spleen | 2 | 2010 | 2286 | 0.020 |
Why?
|
| Data Collection | 2 | 2009 | 3316 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2011 | 927 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2020 | 1937 | 0.020 |
Why?
|
| Peer Review | 1 | 2011 | 217 | 0.020 |
Why?
|
| Computational Biology | 1 | 2021 | 3509 | 0.020 |
Why?
|
| E-Selectin | 1 | 2011 | 577 | 0.020 |
Why?
|
| Glycosylation | 1 | 2011 | 1098 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2010 | 23415 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 1376 | 0.020 |
Why?
|
| Rural Population | 1 | 2019 | 2277 | 0.020 |
Why?
|
| Confidentiality | 1 | 2012 | 608 | 0.020 |
Why?
|
| Phylogeny | 1 | 1996 | 2805 | 0.020 |
Why?
|
| HIV-1 | 2 | 1997 | 6858 | 0.020 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2016 | 992 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1990 | 2185 | 0.020 |
Why?
|
| Tachycardia | 1 | 1990 | 597 | 0.020 |
Why?
|
| Insurance, Medigap | 1 | 2007 | 20 | 0.020 |
Why?
|
| Adiposity | 1 | 2018 | 1879 | 0.020 |
Why?
|
| Mice | 7 | 2023 | 81368 | 0.020 |
Why?
|
| Acute-Phase Proteins | 1 | 2009 | 250 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2023 | 9417 | 0.020 |
Why?
|
| Prosthesis Failure | 1 | 2013 | 1204 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 1055 | 0.020 |
Why?
|
| APACHE | 1 | 2008 | 267 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2019 | 4470 | 0.020 |
Why?
|
| Gasoline | 1 | 2007 | 53 | 0.020 |
Why?
|
| Environmental Pollutants | 1 | 1997 | 1277 | 0.020 |
Why?
|
| Bibliometrics | 1 | 2011 | 352 | 0.020 |
Why?
|
| Spin Labels | 1 | 2008 | 337 | 0.020 |
Why?
|
| Transplantation Conditioning | 1 | 2014 | 1590 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 1646 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2011 | 1128 | 0.020 |
Why?
|
| HIV Seropositivity | 1 | 2012 | 959 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2012 | 2925 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2008 | 13383 | 0.020 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2011 | 420 | 0.020 |
Why?
|
| Workload | 1 | 2012 | 844 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 1996 | 1748 | 0.020 |
Why?
|
| Viremia | 1 | 2009 | 706 | 0.020 |
Why?
|
| Dissent and Disputes | 1 | 2007 | 146 | 0.020 |
Why?
|
| Immune System | 1 | 2011 | 791 | 0.020 |
Why?
|
| Solubility | 1 | 2008 | 1089 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1996 | 2916 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2011 | 1663 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 2079 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2013 | 2114 | 0.020 |
Why?
|
| Administration, Intravaginal | 1 | 2006 | 149 | 0.020 |
Why?
|
| Emergencies | 1 | 2012 | 1217 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2010 | 2214 | 0.020 |
Why?
|
| Syndrome | 1 | 2012 | 3268 | 0.020 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2011 | 739 | 0.020 |
Why?
|
| Pharmacoepidemiology | 1 | 2009 | 350 | 0.020 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2010 | 612 | 0.020 |
Why?
|
| Cell Cycle | 2 | 2010 | 2929 | 0.020 |
Why?
|
| Marital Status | 1 | 2007 | 425 | 0.020 |
Why?
|
| Work | 1 | 2006 | 195 | 0.020 |
Why?
|
| Geriatrics | 1 | 2010 | 387 | 0.020 |
Why?
|
| Health Maintenance Organizations | 1 | 2008 | 658 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2014 | 4802 | 0.020 |
Why?
|
| Glasgow Coma Scale | 1 | 2007 | 579 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2010 | 1125 | 0.020 |
Why?
|
| Urea | 1 | 2007 | 443 | 0.020 |
Why?
|
| Quality of Health Care | 2 | 2011 | 4325 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2007 | 1624 | 0.020 |
Why?
|
| Neurons | 2 | 2011 | 9436 | 0.010 |
Why?
|
| Bacteria | 1 | 1996 | 2192 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2011 | 1788 | 0.010 |
Why?
|
| Life Style | 1 | 1996 | 3907 | 0.010 |
Why?
|
| Sleep | 1 | 2020 | 4764 | 0.010 |
Why?
|
| Aerosols | 1 | 2007 | 635 | 0.010 |
Why?
|
| Contraception Behavior | 1 | 2006 | 180 | 0.010 |
Why?
|
| Gadolinium DTPA | 1 | 2007 | 823 | 0.010 |
Why?
|
| Long-Term Care | 1 | 2008 | 631 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 2009 | 1155 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 3593 | 0.010 |
Why?
|
| Medical Records | 1 | 2009 | 1408 | 0.010 |
Why?
|
| Hypoglycemia | 1 | 2011 | 883 | 0.010 |
Why?
|
| Prostatectomy | 1 | 2012 | 1825 | 0.010 |
Why?
|
| Virus Replication | 1 | 2011 | 2427 | 0.010 |
Why?
|
| International Classification of Diseases | 1 | 2009 | 912 | 0.010 |
Why?
|
| Diet, Cariogenic | 1 | 2003 | 6 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 2747 | 0.010 |
Why?
|
| Korea | 1 | 2003 | 98 | 0.010 |
Why?
|
| DMF Index | 1 | 2003 | 87 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 2639 | 0.010 |
Why?
|
| Epidemiologic Methods | 2 | 1998 | 1335 | 0.010 |
Why?
|
| Carbonates | 1 | 2002 | 21 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2010 | 1799 | 0.010 |
Why?
|
| Fee-for-Service Plans | 1 | 2008 | 697 | 0.010 |
Why?
|
| Vanadates | 1 | 2002 | 82 | 0.010 |
Why?
|
| Fuel Oils | 1 | 2002 | 35 | 0.010 |
Why?
|
| Registries | 2 | 2010 | 8209 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 1995 | 2518 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 2012 | 1859 | 0.010 |
Why?
|
| Phonetics | 1 | 2004 | 198 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 6188 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2006 | 2261 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 6807 | 0.010 |
Why?
|
| Radiography | 1 | 2013 | 6961 | 0.010 |
Why?
|
| Mitochondria | 1 | 1996 | 3619 | 0.010 |
Why?
|
| Hippocampus | 1 | 2015 | 3762 | 0.010 |
Why?
|
| Ethanolamines | 1 | 2002 | 153 | 0.010 |
Why?
|
| Hematologic Neoplasms | 1 | 2014 | 1896 | 0.010 |
Why?
|
| Medically Uninsured | 1 | 2007 | 835 | 0.010 |
Why?
|
| Bronchial Provocation Tests | 1 | 2001 | 216 | 0.010 |
Why?
|
| Students | 2 | 2005 | 1736 | 0.010 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2009 | 1002 | 0.010 |
Why?
|
| Observer Variation | 1 | 2007 | 2607 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2012 | 2515 | 0.010 |
Why?
|
| Pneumonectomy | 1 | 2008 | 1119 | 0.010 |
Why?
|
| Income | 1 | 2009 | 1870 | 0.010 |
Why?
|
| Accidents, Occupational | 1 | 2002 | 249 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6074 | 0.010 |
Why?
|
| China | 1 | 2007 | 2374 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2006 | 2278 | 0.010 |
Why?
|
| Phosphocreatine | 1 | 2001 | 261 | 0.010 |
Why?
|
| Cell Line | 2 | 2011 | 15577 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 1992 | 1924 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7390 | 0.010 |
Why?
|
| Cloning, Molecular | 2 | 1999 | 4172 | 0.010 |
Why?
|
| Causality | 1 | 2007 | 1241 | 0.010 |
Why?
|
| Apoptosis | 1 | 1996 | 9476 | 0.010 |
Why?
|
| Lymph Node Excision | 1 | 2006 | 1269 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2015 | 6635 | 0.010 |
Why?
|
| Cell Survival | 1 | 2010 | 5780 | 0.010 |
Why?
|
| Phosphorus | 1 | 2001 | 332 | 0.010 |
Why?
|
| Osteoporosis | 1 | 2010 | 1604 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2007 | 2897 | 0.010 |
Why?
|
| Triage | 1 | 2007 | 984 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2006 | 1436 | 0.010 |
Why?
|
| Age Distribution | 1 | 2006 | 2872 | 0.010 |
Why?
|
| Histones | 1 | 2010 | 2577 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2010 | 4140 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2010 | 5863 | 0.010 |
Why?
|
| Particle Size | 1 | 2004 | 1648 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2010 | 2565 | 0.010 |
Why?
|
| Metals | 1 | 2004 | 719 | 0.010 |
Why?
|
| Thrombosis | 1 | 2013 | 2942 | 0.010 |
Why?
|
| Physical Exertion | 1 | 2002 | 668 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2011 | 3037 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 2002 | 673 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2019 | 6826 | 0.010 |
Why?
|
| Cardiac Volume | 1 | 1999 | 196 | 0.010 |
Why?
|
| Prostate | 1 | 2007 | 1773 | 0.010 |
Why?
|
| Potassium | 1 | 2002 | 1311 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 10754 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2009 | 3149 | 0.010 |
Why?
|
| Emergency Medicine | 1 | 2007 | 1197 | 0.010 |
Why?
|
| Electric Impedance | 1 | 2002 | 751 | 0.010 |
Why?
|
| Phosphates | 1 | 2001 | 769 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2011 | 3882 | 0.010 |
Why?
|
| HIV Long Terminal Repeat | 1 | 1997 | 85 | 0.010 |
Why?
|
| Defective Viruses | 1 | 1997 | 89 | 0.010 |
Why?
|
| Vulnerable Populations | 1 | 2003 | 705 | 0.010 |
Why?
|
| Disease | 1 | 2002 | 670 | 0.010 |
Why?
|
| Ribonucleosides | 1 | 1997 | 79 | 0.010 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 1997 | 85 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2001 | 2495 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1994 | 11874 | 0.010 |
Why?
|
| Synaptophysin | 1 | 1996 | 139 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1996 | 237 | 0.010 |
Why?
|
| Monte Carlo Method | 1 | 2001 | 1257 | 0.010 |
Why?
|
| Body Height | 1 | 2002 | 1565 | 0.010 |
Why?
|
| Functional Residual Capacity | 1 | 1995 | 70 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1999 | 1989 | 0.010 |
Why?
|
| Arm | 1 | 1999 | 588 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 1988 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1997 | 685 | 0.010 |
Why?
|
| Base Sequence | 2 | 1999 | 12420 | 0.010 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1997 | 433 | 0.010 |
Why?
|
| Public Health | 2 | 1998 | 2671 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 18937 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2010 | 10429 | 0.010 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1994 | 178 | 0.010 |
Why?
|
| Mice, Transgenic | 2 | 1997 | 9526 | 0.010 |
Why?
|
| Medicaid | 1 | 2007 | 2814 | 0.010 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 1994 | 183 | 0.010 |
Why?
|
| Atmosphere Exposure Chambers | 1 | 1993 | 51 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 16968 | 0.010 |
Why?
|
| Cadmium | 1 | 1994 | 214 | 0.010 |
Why?
|
| Bronchoscopes | 1 | 1993 | 64 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 1999 | 1085 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1997 | 1900 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1996 | 1433 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 22117 | 0.010 |
Why?
|
| Tidal Volume | 1 | 1995 | 488 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1994 | 1085 | 0.010 |
Why?
|
| Hematocrit | 1 | 1994 | 623 | 0.010 |
Why?
|
| Particulate Matter | 1 | 2004 | 2602 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 1996 | 747 | 0.010 |
Why?
|
| Poly A | 1 | 1992 | 181 | 0.010 |
Why?
|
| Zidovudine | 1 | 1994 | 624 | 0.010 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1992 | 176 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1999 | 6126 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1993 | 755 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 1058 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1997 | 1492 | 0.010 |
Why?
|
| Zinc | 1 | 1994 | 687 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1992 | 1545 | 0.010 |
Why?
|
| Gene Deletion | 1 | 1997 | 2659 | 0.010 |
Why?
|
| Bronchi | 1 | 1993 | 846 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1993 | 1756 | 0.010 |
Why?
|
| Gene Library | 1 | 1992 | 1055 | 0.010 |
Why?
|
| Random Allocation | 1 | 1993 | 2392 | 0.000 |
Why?
|
| Rabbits | 1 | 1994 | 4770 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1996 | 3965 | 0.000 |
Why?
|
| Protein Kinases | 1 | 1994 | 1606 | 0.000 |
Why?
|
| Bronchoscopy | 1 | 1993 | 909 | 0.000 |
Why?
|
| DNA, Neoplasm | 1 | 1992 | 1743 | 0.000 |
Why?
|
| Residence Characteristics | 1 | 1996 | 2092 | 0.000 |
Why?
|
| Up-Regulation | 1 | 1994 | 4117 | 0.000 |
Why?
|
| Intraoperative Complications | 1 | 1992 | 1161 | 0.000 |
Why?
|
| Promoter Regions, Genetic | 1 | 1994 | 5780 | 0.000 |
Why?
|
| Cell Nucleus | 1 | 1992 | 2894 | 0.000 |
Why?
|
| RNA | 1 | 1992 | 2713 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1992 | 12759 | 0.000 |
Why?
|